IRADIMED CORPORATION
IRMDNASDAQHealthcareMedical Devices
As of Oct 23, 2026 close
- Market cap
- $1.10B
- P/E (TTM)
- 47.92
- Forward P/E
- 43.84
- Dividend yield
- 1.45%
- 52-week range
- $73.99$107.90
- Volume (live)
- -
- Avg. volume (3M)
- 118.24K
IRADIMED (IRMD) Stock Price & Financial Analysis
IRADIMED Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $85.46 - $87.90 |
|---|---|
| 52-Week High | $107.90 |
| 52-Week Low | $73.99 |
| Open | $87.44 |
| Volume (last close) | 106.76K |
| Average Volume (3M) | 118.24K |
| Revenue (TTM) | 86.34M |
|---|---|
| Net Income (TTM) | 23.05M |
| Free Cash Flow (TTM) | 24.67M |
| EPS (TTM) | $1.79 |
| Profit Margin | 26.70% |
| Operating Margin | 31.92% |
| Return on Equity (ROE) | 22.66% |
| Debt to Equity | 0.00 |
| Annual Dividend | $1.27 |
|---|---|
| Dividend Yield | 1.45% |
| Payout Ratio | 70.89% |
| Last Dividend Ex-Date | Aug 14, 2026 |
| Market Cap | 1.10B |
|---|---|
| Shares Outstanding | 12.87M |
| P/E Ratio (TTM) | 47.92 |
| Forward P/E | 43.84 |
| Price to Sales (P/S) | 12.79 |
| Price to Book (P/B) | 10.86 |
| EV/EBITDA | 35.50 |
| 50-Day MA | $86.14 |
|---|---|
| 200-Day MA | $93.12 |
| 1-Year Change | +12.43% |
Source: Market prices and company fundamentals. Data as of Oct 23, 2026. Data sources and methodology
IRADIMED at a Glance
As of the Oct 23, 2026 close, IRADIMED (IRMD) has a market capitalization of $1.10B. The stock trades at 47.9× trailing earnings, 43.8× forward earnings and 12.8× sales. Over the trailing twelve months it earned $23.05M on revenue of $86.34M (a 26.7% profit margin) and generated $24.67M of free cash flow. Revenue grew 11.2% year over year.
As of its latest reported balance sheet, it holds $59.08M in cash and securities against $0.00 of debt, a net cash position of $59.08M.
IRADIMED pays a quarterly dividend totaling $1.27 per share a year, a 1.45% yield at the Oct 23, 2026 close, with a 71% payout ratio and 1 consecutive year of dividend increases.
The share price is up 12.4% over the past year. At $85.82 (the Oct 23, 2026 close) it sits within its 52-week range of $73.99 to $107.90, below its 200-day moving average of $93.12.
Frequently Asked Questions About IRADIMED
What is the current stock price for IRMD?
As of the Oct 23, 2026 close, IRMD stock trades at $85.82. The 52-week range is $73.99–$107.90, with a day range of $85.46–$87.90.
What is the P/E ratio for IRMD?
As of the Oct 23, 2026 close, IRADIMED's trailing twelve-month (TTM) P/E ratio is 47.9, meaning investors pay $47.9 for every $1 of annual earnings. The forward P/E is 43.8, reflecting analyst expectations for future earnings. IRADIMED operates in the Healthcare sector.
Does IRMD pay dividends?
Yes, IRADIMED pays a 1.45% annual dividend yield as of the Oct 23, 2026 close ($1.27 per share a year). The trailing twelve-month payout ratio is 70.9%. The most recent ex-dividend date was August 14, 2026.
What do analysts recommend for IRMD?
Analyst ratings and recommendations for IRMD are displayed in the Analyst Consensus section, including buy/hold/sell distribution and 12-month price targets.
What is the market cap of IRMD?
As of the Oct 23, 2026 close, IRADIMED's market capitalization is $1.10B, classifying it as a small-cap company. IRADIMED operates in the Healthcare sector within the Medical Devices industry.